Pyxis Oncology Q2 EPS $(0.41) Beats $(0.66) Estimate
Portfolio Pulse from Benzinga Newsdesk
Pyxis Oncology reported Q2 losses of $(0.41) per share, beating the analyst consensus estimate of $(0.66) by 37.88%. This represents a 48.1% increase over losses from the same period last year.
August 11, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pyxis Oncology's Q2 earnings beat estimates, with losses of $(0.41) per share, a 37.88% improvement over the expected $(0.66). This is also a 48.1% increase over last year's losses.
Pyxis Oncology's Q2 earnings beat analyst estimates, which is generally seen as a positive sign by investors. This could lead to a short-term increase in the company's stock price. The fact that the losses are also less than the same period last year further strengthens this positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100